Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02991729 · ClinicalTrials.gov registry record · NA
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT02991729 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 197 participants.
The verdict
NCT02991729, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
The investigators aim to assess whether use of a novel, tablet-based computerized decision aid for aneuploidy screening is similar to routine care with a brief genetic counseling visit in improving patient knowledge and decreasing decisional conflict.
Interventions
- OTHER iPad-based decision aid
- OTHER Genetic counseling appointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2017-01-20 |
| Est. Completion | 2018-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02991729
The ClinicalTrials.gov registry entry for NCT02991729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iPad-based decision aid is the first listed.
NCT02991729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02991729 about?
NCT02991729 is a clinical study titled "Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening". The investigators aim to assess whether use of a novel, tablet-based computerized decision aid for aneuploidy screening is similar to routine care with a brief genetic counseling visit in improving patient knowledge and decreasing decisional conflict.
What is the current status of trial NCT02991729?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2017-01-20. Estimated completion is 2018-01-12.
What interventions are being tested in trial NCT02991729?
The interventions under investigation include: iPad-based decision aid (OTHER), Genetic counseling appointment (OTHER).
Who is sponsoring clinical trial NCT02991729?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.